O. Opota

Discipline

Anthropologie biologique (3) Economies et finances (1)

Type de document

Articles (35) Recensions (11)

Co-auteur

Date

Source

Mot-clé

Human beings (22) Diagnosis (16) Diagnosis (16) Patients (13) Patients (13) investigation (12) Detection (12) épuration (11) Purification (11) temps (durée) (10) Time (10) Examinations (10) Infections (10) infection (9) Treatment (9) Tuberculosis (9) Performance (9) Infection (9) Tuberculosis (9) test (8) laboratoire (8) ADN (8) méthode (8) Case (8) Grammar, Comparative and general--Case (8) DNA (8) Case (8) Bacteria (8) Performance (8) analyse (7)

Documents écrit par O. Opota (35) | parle de O. Opota (0)

Nanomotion technology in combination with machine learning: a new approach for a rapid antibiotic susceptibility test for Mycobacterium tuberculosis.
A. Vocat et al.
Performance of microbiological tests for tuberculosis diagnostic according to the type of respiratory specimen: A 10-year retrospective study.
M.O. Boldi et al. (2023)
Utility of Polymerase Chain Reaction in Nasopharyngeal Swabs for Identifying Respiratory Bacteria Causing Community-Acquired Pneumonia.
Y. Demars et al. (29 juin 2022)
Assessment of SARS-CoV-2 tests costs and reimbursement tariffs readjustments during the COVID-19 pandemic.
G. Caruana et al. (9 mai 2022)
Tularémie pulmonaire : un diagnostic à ne pas manquer [Pulmonary tularemia : a diagnosis not to be missed]
P. Uriel Valladares et al. (13 avr. 2022)
A refractory tenosynovitis of the wrist: a case report.
A. Boudon et al. (21 févr. 2022)
Performance of RT-PCR on Saliva Specimens Compared With Nasopharyngeal Swabs for the Detection of SARS-CoV-2 in Children: A Prospective Comparative Clinical Trial.
Y. Fougère et al. (1 août 2021)
The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients.
G. Caruana et al.
Impact of different SARS-CoV-2 assays on laboratory turnaround time.
B. Marquis et al.
Transplantation de microbiote fécal : de l’évidence aux réalités du terrain [Fecal microbiota transplantation: from the evidence to the realty of the field]
A. Ballif et al. (14 avr. 2021)
SARS-CoV-2 N501Y Introductions and Transmissions in Switzerland from Beginning of October 2020 to February 2021-Implementation of Swiss-Wide Diagnostic Screening and Whole Genome Sequencing.
A.R. Goncalves Cabecinhas et al. (25 mars 2021)
No evidence of SARS-CoV-2 circulation before identification of the first Swiss SARS-CoV-2 case.
L. Lhopitallier et al.
Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results.
G. Caruana et al.
Genome sequencing of Mycobacterium tuberculosis clinical isolates revealed isoniazid resistance mechanisms undetected by conventional molecular methods.
S. Laurent et al.
SARS-CoV-2, un point dans la tourmente [SARS-CoV-2, a point in the storm]
E. Tadini et al. (6 mai 2020)
CAPNOCYTOPHAGA CANIMORSUS ENDOPHTHALMITIS AFTER CATARACT SURGERY LINKED TO SALIVARY DOG-TO-HUMAN TRANSMISSION.
F. Thommen et al. (2020)
Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses.
D. Jacot et al. (2020)
The rapid molecular test Xpert MTB/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection.
O. Opota et al.
Whole-genome sequencing for rapid, reliable and routine investigation of Mycobacterium tuberculosis transmission in local communities.
F. Zakham et al.
Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting.
O. Opota et al.
Improvement in Tuberculosis Outcomes With a Combined Medical and Social Approach.
J. Mazza-Stalder et al. (2019)
How to: identify non-tuberculous Mycobacterium species using MALDI-TOF mass spectrometry.
F. Alcaide et al.
Detection of respiratory bacterial pathogens causing atypical pneumonia by multiplex Lightmix® RT-PCR.
K. Wagner et al.
Genomics of the new species Kingella negevensis: diagnostic issues and identification of a locus encoding a RTX toxin.
O. Opota et al.
Mentor-mentee relationship in clinical microbiology.
O. Opota et al.

next